Last reviewed · How we verify
B1:SG with SHR1210 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
B1:SG with SHR1210 (B1:SG with SHR1210) — Fudan University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| B1:SG with SHR1210 TARGET | B1:SG with SHR1210 | Fudan University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- B1:SG with SHR1210 CI watch — RSS
- B1:SG with SHR1210 CI watch — Atom
- B1:SG with SHR1210 CI watch — JSON
- B1:SG with SHR1210 alone — RSS
Cite this brief
Drug Landscape (2026). B1:SG with SHR1210 — Competitive Intelligence Brief. https://druglandscape.com/ci/b1-sg-with-shr1210. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab